Requirement | Level of compliance | ||
---|---|---|---|
Séralini et al.[3] | Hammond et al.[14] | Monsanto[12] | |
Study objectives need to be clearly stated a priori in the study protocol | Medium | Medium | Medium |
Suitable controls for all treatment groups need to be presented | No data shown (high)a | High | High |
Biological relevance of the rat strain used should be justified | Low | Low | Low |
Measures taken to reduce the risk of bias (e.g. blinding) need to be taken | No data shown (high)a | No data shown | No data shown |
Critical information about the diet composition need to be reported | No data shown | No data shown | High |
Details of the storage conditions of the feed need to be provided | No data shown | No data shown | No data shown |
Contamination of the diets, e.g. by mycotoxins, pesticides etc., need to be reported | No data shown (medium)a | No data shown | High |
All collected endpoints should be reported openly and transparently | No data shown | Medium | High |
The presented data need to ensure the calculation of exposure to the test substance | No data shown | No data shown | Medium |
The sample size (power) calculation must be presented, especially when the study objectives are unclear | Low | Low | Low |
(but reference to OECD GL408) | (but reference to OECD GL408) |